Nadeem Ahmed, Alharbi Naif O, Vliagoftis Harissios, Tyagi Manoj, Ahmad Sheikh F, Sayed-Ahmed Mohamed M
Department of Pharmacology & Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Pulmonary Research Group, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Immunology. 2015 Jul;145(3):391-403. doi: 10.1111/imm.12453.
Airway epithelial cells (AECs) express a variety of receptors, which sense danger signals from various aeroallergens/pathogens being inhaled constantly. Proteinase-activated receptor 2 (PAR-2) is one such receptor and is activated by cockroach allergens, which have intrinsic serine proteinase activity. Recently, dual oxidases (DUOX), especially DUOX-2, have been shown to be involved in airway inflammation in response to Toll-like receptor activation. However, the association between PAR-2 and DUOX-2 has not been explored in airways of allergic mice. Therefore, this study investigated the contribution of DUOX-2/reactive oxygen species (ROS) signalling in airway reactivity and inflammation after PAR-2 activation. Mice were sensitized intraperitoneally with intact cockroach allergen extract (CE) in the presence of aluminium hydroxide followed by intranasal challenge with CE. Mice were then assessed for airway reactivity, inflammation, oxidative stress (DUOX-2, ROS, inducible nitric oxide synthase, nitrite, nitrotyrosine and protein carbonyls) and apoptosis (Bax, Bcl-2, caspase-3). Challenge with CE led to up-regulation of DUOX-2 and ROS in AECs with concomitant increases in airway reactivity/inflammation and parameters of oxidative stress, and apoptosis. All of these changes were significantly inhibited by intranasal administration of ENMD-1068, a small molecule antagonist of PAR-2 in allergic mice. Administration of diphenyliodonium to allergic mice also led to improvement of allergic airway responses via inhibition of the DUOX-2/ROS pathway; however, these effects were less pronounced than PAR-2 antagonism. The current study suggests that PAR-2 activation leads to up-regulation of the DUOX-2/ROS pathway in AECs, which is involved in regulation of airway reactivity and inflammation via oxidative stress and apoptosis.
气道上皮细胞(AECs)表达多种受体,这些受体可感知不断吸入的各种气传变应原/病原体发出的危险信号。蛋白酶激活受体2(PAR - 2)就是这样一种受体,它可被具有内在丝氨酸蛋白酶活性的蟑螂变应原激活。最近,双氧化酶(DUOX),尤其是DUOX - 2,已被证明参与了对Toll样受体激活的气道炎症反应。然而,在过敏性小鼠的气道中,PAR - 2与DUOX - 2之间的关联尚未得到研究。因此,本研究调查了PAR - 2激活后DUOX - 2/活性氧(ROS)信号通路在气道反应性和炎症中的作用。在氢氧化铝存在的情况下,用完整的蟑螂变应原提取物(CE)对小鼠进行腹腔致敏,随后用CE进行鼻内激发。然后评估小鼠的气道反应性、炎症、氧化应激(DUOX - 2、ROS、诱导型一氧化氮合酶、亚硝酸盐、硝基酪氨酸和蛋白质羰基)和细胞凋亡(Bax、Bcl - 2、半胱天冬酶 - 3)。用CE激发导致AECs中DUOX - 2和ROS上调,同时气道反应性/炎症以及氧化应激和细胞凋亡参数增加。在过敏性小鼠中,鼻内给予PAR - 2的小分子拮抗剂ENMD - 1068可显著抑制所有这些变化。向过敏性小鼠施用二苯基碘鎓也通过抑制DUOX - 2/ROS途径改善了过敏性气道反应;然而,这些作用不如PAR - 2拮抗作用明显。当前研究表明,PAR - 2激活导致AECs中DUOX - 2/ROS途径上调,该途径通过氧化应激和细胞凋亡参与气道反应性和炎症的调节。